Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ITOS |
---|---|---|
09:32 ET | 62455 | 11.2 |
09:34 ET | 850 | 11.28 |
09:36 ET | 2722 | 11.15 |
09:38 ET | 3707 | 11.17 |
09:39 ET | 400 | 11.21 |
09:41 ET | 2033 | 11.2 |
09:45 ET | 100 | 11.175 |
09:48 ET | 2109 | 11.19 |
09:50 ET | 200 | 11.12 |
09:52 ET | 100 | 11.13 |
09:54 ET | 400 | 11.13 |
09:56 ET | 8130 | 11.045 |
09:57 ET | 14370 | 11.15 |
09:59 ET | 1573 | 11.16 |
10:01 ET | 4070 | 11.17 |
10:03 ET | 2396 | 11.15 |
10:06 ET | 700 | 11.13 |
10:08 ET | 3491 | 11.21 |
10:10 ET | 1496 | 11.19 |
10:12 ET | 600 | 11.2 |
10:15 ET | 2010 | 11.33 |
10:17 ET | 300 | 11.355 |
10:19 ET | 9799 | 11.31 |
10:21 ET | 200 | 11.28 |
10:24 ET | 200 | 11.27 |
10:26 ET | 1918 | 11.255 |
10:30 ET | 100 | 11.26 |
10:32 ET | 1051 | 11.289 |
10:33 ET | 824 | 11.3 |
10:35 ET | 1562 | 11.31 |
10:39 ET | 100 | 11.34 |
10:42 ET | 600 | 11.34 |
10:44 ET | 100 | 11.3459 |
10:48 ET | 2317 | 11.34 |
10:50 ET | 26077 | 11.34 |
10:51 ET | 1000 | 11.35 |
10:55 ET | 2789 | 11.42 |
10:57 ET | 1712 | 11.37 |
11:00 ET | 1000 | 11.4 |
11:02 ET | 100 | 11.39 |
11:04 ET | 3300 | 11.39 |
11:06 ET | 300 | 11.385 |
11:08 ET | 1250 | 11.3676 |
11:11 ET | 835 | 11.35 |
11:15 ET | 300 | 11.355 |
11:20 ET | 820 | 11.32 |
11:22 ET | 306 | 11.345 |
11:24 ET | 1818 | 11.29 |
11:31 ET | 100 | 11.24 |
11:33 ET | 200 | 11.18 |
11:36 ET | 2184 | 11.1801 |
11:38 ET | 427 | 11.17 |
11:40 ET | 1100 | 11.24 |
11:42 ET | 700 | 11.23 |
11:45 ET | 300 | 11.24 |
11:47 ET | 200 | 11.22 |
11:49 ET | 200 | 11.24 |
11:51 ET | 915 | 11.28 |
11:54 ET | 724 | 11.26 |
12:00 ET | 600 | 11.23 |
12:02 ET | 100 | 11.21 |
12:03 ET | 200 | 11.22 |
12:07 ET | 100 | 11.24 |
12:09 ET | 326 | 11.26 |
12:14 ET | 1400 | 11.24 |
12:16 ET | 100 | 11.2 |
12:18 ET | 100 | 11.2 |
12:21 ET | 1700 | 11.165 |
12:23 ET | 474 | 11.164 |
12:25 ET | 115 | 11.18 |
12:30 ET | 1434 | 11.16 |
12:32 ET | 300 | 11.13 |
12:38 ET | 424 | 11.105 |
12:39 ET | 1000 | 11.13 |
12:45 ET | 100 | 11.13 |
12:48 ET | 500 | 11.135 |
12:50 ET | 637 | 11.16 |
12:52 ET | 100 | 11.175 |
12:54 ET | 100 | 11.175 |
12:56 ET | 1188 | 11.17 |
12:57 ET | 2753 | 11.165 |
01:01 ET | 300 | 11.17 |
01:03 ET | 972 | 11.143 |
01:06 ET | 378 | 11.15 |
01:10 ET | 6527 | 11.175 |
01:12 ET | 1337 | 11.24 |
01:14 ET | 2400 | 11.1908 |
01:15 ET | 693 | 11.21 |
01:17 ET | 900 | 11.23 |
01:19 ET | 200 | 11.2 |
01:21 ET | 439 | 11.2 |
01:24 ET | 710 | 11.16 |
01:26 ET | 100 | 11.15 |
01:28 ET | 300 | 11.15 |
01:30 ET | 100 | 11.13 |
01:32 ET | 1005 | 11.11 |
01:35 ET | 750 | 11.11 |
01:37 ET | 200 | 11.09 |
01:39 ET | 400 | 11.11 |
01:42 ET | 600 | 11.09 |
01:44 ET | 100 | 11.09 |
01:46 ET | 1771 | 11.12 |
01:48 ET | 800 | 11.06 |
01:50 ET | 100 | 11.05 |
01:51 ET | 500 | 11.07 |
01:53 ET | 100 | 11.06 |
01:55 ET | 700 | 11.06 |
01:57 ET | 1000 | 11.05 |
02:00 ET | 2900 | 11.07 |
02:02 ET | 100 | 11.05 |
02:04 ET | 300 | 11.04 |
02:06 ET | 761 | 11.02 |
02:08 ET | 337 | 11.0312 |
02:09 ET | 346 | 11.0324 |
02:11 ET | 734 | 11.04 |
02:13 ET | 1900 | 11.045 |
02:15 ET | 2051 | 11.055 |
02:18 ET | 200 | 11.05 |
02:20 ET | 100 | 11.05 |
02:22 ET | 800 | 11.07 |
02:24 ET | 800 | 11.11 |
02:26 ET | 27809 | 11.18 |
02:27 ET | 6347 | 11.17 |
02:29 ET | 2800 | 11.16 |
02:31 ET | 8491 | 11.24 |
02:33 ET | 330 | 11.26 |
02:36 ET | 2219 | 11.22 |
02:38 ET | 100 | 11.23 |
02:40 ET | 1744 | 11.235 |
02:42 ET | 667 | 11.24 |
02:44 ET | 1100 | 11.2719 |
02:45 ET | 300 | 11.275 |
02:47 ET | 1275 | 11.32 |
02:49 ET | 928 | 11.32 |
02:51 ET | 1130 | 11.31 |
02:54 ET | 1385 | 11.32 |
02:56 ET | 200 | 11.325 |
02:58 ET | 2303 | 11.31 |
03:00 ET | 1293 | 11.295 |
03:02 ET | 1641 | 11.27 |
03:03 ET | 400 | 11.27 |
03:05 ET | 866 | 11.255 |
03:07 ET | 2163 | 11.28 |
03:09 ET | 999 | 11.25 |
03:12 ET | 1514 | 11.26 |
03:16 ET | 1800 | 11.23 |
03:18 ET | 1164 | 11.2 |
03:20 ET | 907 | 11.215 |
03:21 ET | 1030 | 11.225 |
03:23 ET | 700 | 11.23 |
03:25 ET | 1800 | 11.21 |
03:27 ET | 5483 | 11.22 |
03:30 ET | 5030 | 11.22 |
03:32 ET | 4443 | 11.23 |
03:34 ET | 1000 | 11.25 |
03:36 ET | 566 | 11.26 |
03:38 ET | 1036 | 11.275 |
03:39 ET | 3962 | 11.29 |
03:41 ET | 500 | 11.27 |
03:43 ET | 600 | 11.285 |
03:45 ET | 2153 | 11.26 |
03:48 ET | 1830 | 11.2409 |
03:50 ET | 1109 | 11.245 |
03:52 ET | 3585 | 11.29 |
03:54 ET | 5123 | 11.265 |
03:56 ET | 4963 | 11.25 |
03:57 ET | 4017 | 11.225 |
03:59 ET | 368811 | 11.26 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Iteos Therapeutics Inc | 409.8M | -3.8x | --- |
Verve Therapeutics Inc | 455.3M | -2.0x | --- |
Taysha Gene Therapies Inc | 448.8M | -2.4x | --- |
AC Immune SA | 364.4M | -4.9x | --- |
MeiraGTx Holdings PLC | 336.5M | -2.8x | --- |
Northwest Biotherapeutics Inc | 399.4M | -4.9x | --- |
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways. Its lead antibody product candidate, belrestotug, also known as EOS-448/GSK4428859A, is an antagonist of TIGIT, an immune checkpoint with multiple mechanisms of action. Its advanced program is inupadenant, also known as EOS-850, a next-generation adenosine 2A receptor (A2AR) antagonist tailored to overcome the specific adenosine-mediated immunosuppression found in the tumor microenvironment. Its program to initiate clinical trials is EOS-984, a potentially first-in-class small molecule focused on a new mechanism in the adenosine pathway by targeting equilibrative nucleoside transporter 1 (ENT1), a dominant transporter of adenosine on lymphocytes involved in T cell metabolism.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $409.8M |
---|---|
Revenue (TTM) | $35.0M |
Shares Outstanding | 36.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.39 |
EPS | $-3.00 |
Book Value | $16.05 |
P/E Ratio | -3.8x |
Price/Sales (TTM) | 11.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -413.78% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.